Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Completed 6Unknown 3Terminated 3Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 1

Conditions

Peripheral Nervous System Diseases 1Leiomyoma 1Hemorrhage 1Hand-Foot Syndrome 1Breast Neoplasms 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Interventional × Vitamin B 6 × Clear all
NCT02209545 2023-09-07

Misoprostol for Reduction of Blood Loss During Fibroid Surgery

Northwestern University

Phase 4 Terminated
47 enrolled 4 charts

Hemorrhage, Leiomyoma

NCT00767689 2023-06-15

Vitamin B6 Can Prevent Hand and Foot Syndrome in Cancer Patients Capecitabine Chemotherapy

Cook County Health

Phase NA Terminated
6 enrolled

Hand-Foot Syndrome

NCT02795572 2019-07-05

CIPN

AHS Cancer Control Alberta

Phase 2 Terminated
13 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡